Humacyte Ownership | Who Owns Humacyte?


OverviewForecastRevenueFinancialsChartTranscripts

Humacyte Ownership Summary


Humacyte is owned by 36.63% institutional investors, 19.74% insiders, and 43.62% retail investors. Blackrock is the largest institutional shareholder, holding 6.60% of HUMA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.42% of its assets in Humacyte shares.

HUMA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockHumacyte36.63%19.74%43.62%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock7.14M6.60%$34.27M
Blackrock funding, inc. /de9.95M6.40%$20.79M
Vanguard group5.60M4.69%$28.29M
State street4.61M3.86%$23.28M
Woodline partners lp2.85M2.39%$14.39M
Geode capital management2.14M1.79%$10.79M
Marshall wace, llp2.64M1.70%$5.52M
Centerbook partners lp1.28M1.07%$6.46M
Ubs group1.12M0.94%$5.66M
Two sigma investments, lp919.10K0.77%$4.64M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Centerbook partners lp1.28M0.39%$6.46M
Lji wealth management185.00K0.18%$934.25K
Endowment wealth management109.46K0.10%$192.05K
Woodline partners lp2.85M0.10%$14.39M
Wealth effects102.17K0.08%$213.53K
Gsa capital partners llp147.44K0.06%$745.00K
Clough capital partners l p240.93K0.05%$504.00K
Clarus wealth advisors39.97K0.05%$102.72K
Lasalle st. investment advisors60.49K0.03%$126.00K
Hamilton lane advisors21.89K0.03%$45.76K

Top Buyers

HolderShares% AssetsChange
Marshall wace, llp2.64M0.01%2.59M
Blackrock7.14M0.00%2.35M
Woodline partners lp2.85M0.10%2.00M
Blackrock funding, inc. /de9.95M0.00%1.72M
Centerbook partners lp1.28M0.39%1.28M

Top Sellers

HolderShares% AssetsChange
Heights capital management---4.03M
Ra capital management---3.31M
Aigh capital management---2.16M
Toronto dominion bank---2.13M
Monashee investment management---2.00M

New Positions

HolderShares% AssetsChangeValue
Centerbook partners lp1.28M0.39%1.28M$6.46M
Franklin resources433.48K0.00%433.48K$2.19M
Lji wealth management185.00K0.18%185.00K$934.25K
Ieq capital91.90K0.00%91.90K$192.06K
Thompson siegel & walmsley35.00K0.00%35.00K$177.00K

Sold Out

HolderChange
Org partners-10.00
Russell investments group-35.00
Gen-wealth partners-85.00
Bare financial services-104.00
Gamma investing-112.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025163-6.86%56,940,940-6.40%361.71%1048.33%26-29.73%
Mar 31, 20251762.92%61,024,54445.00%463.74%97-37-7.50%
Dec 31, 202487-42.38%22,175,982-38.04%182.07%52-41.57%18-30.77%
Sep 30, 202414914.62%35,789,08014.71%293.61%90-8.16%2578.57%
Jun 30, 202412927.72%31,200,46133.99%285.69%97110.87%14-58.82%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv3.78M2.42%-33.25K
iShares Russell 2000 ETF2.92M1.89%-55.55K
SPDR® S&P Biotech ETF2.24M1.45%55.44K
Vanguard Institutional Extnd Mkt Idx Tr1.28M0.82%-561.50K
Nuveen Quant Small Cap Equity R6728.27K0.61%-
Fidelity Small Cap Index919.67K0.59%-9.47K
iShares Russell 2000 Value ETF827.91K0.53%614.00
iShares Biotechnology ETF765.10K0.49%6.54K
MEDICAL BioHealth EUR Acc718.45K0.46%-
Fidelity Extended Market Index626.88K0.40%99.91K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 18, 2025Dougan Brady W-Sell$1.01M
Aug 20, 2025Dougan Brady W-Sell$934.86K
Aug 19, 2025Dougan Brady W-Sell$1.79M
Aug 19, 2025Niklason Laura E President, CEO and DirectorSell$1.79M
Aug 18, 2025Niklason Laura E President, CEO and DirectorSell$1.01M

Insider Transactions Trends


DateBuySell
2025 Q3-6
2025 Q26-
2025 Q1--
2024 Q436
2024 Q3313

HUMA Ownership FAQ


Who Owns Humacyte?

Humacyte shareholders are primarily institutional investors at 36.63%, followed by 19.74% insiders and 43.63% retail investors. The average institutional ownership in Humacyte's industry, Biotech Stocks , is 306.59%, which Humacyte falls below.

Who owns the most shares of Humacyte?

Humacyte’s largest shareholders are Blackrock (7.14M shares, 6.60%), Blackrock funding, inc. /de (9.95M shares, 6.40%), and Vanguard group (5.6M shares, 4.69%). Together, they hold 17.69% of Humacyte’s total shares outstanding.

Does Blackrock own Humacyte?

Yes, BlackRock owns 6.60% of Humacyte, totaling 7.14M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 34.27M$. In the last quarter, BlackRock increased its holdings by 2.35M shares, a 49.10% change.

Who is Humacyte’s biggest shareholder by percentage of total assets invested?

Centerbook partners lp is Humacyte’s biggest shareholder by percentage of total assets invested, with 0.39% of its assets in 1.28M Humacyte shares, valued at 6.46M$.

Who is the top mutual fund holder of Humacyte shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Humacyte shares, with 2.42% of its total shares outstanding invested in 3.78M Humacyte shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools